Treatment of relapse of breast cancer after adjuvant systemic therapy — Review and guidelines for future research-Reference-Cited by-同舟云学术

Treatment of relapse of breast cancer after adjuvant systemic therapy — Review and guidelines for future research

Published:1994-01 Issue:1 Volume:30 Page:106-111
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Rubens R.D.,Bajetta E.,Bonneterre J.,Klijn J.G.M.,Lonning P.E.,Paridaens R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference62 articles.

1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy;Lancet,1992

2. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy;Lancet,1992

3. Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high risk breast cancer;Chlebowski;Cancer Res,1981

4. Management of breast cancer patients failing adjuvant chemotherapy with adriamycin containing regimens;Buzdar;Cancer,1981

5. Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy;Valagussa;Cancer,1986

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: Results of a multicenter phase II study1 1On behalf of Gruppo Oncologico Italia Meridionale.;Seminars in Oncology;2004-04

2. Outpatient Therapy in Metastatic Breast Cancer. A Retrospective Study of 90 Patients Treated in an Oncology Group Practice;Oncology Research and Treatment;2004

3. Locally Advanced, Locally Recurrent, and Metastatic Breast Cancer;Oncologic Therapies;2003

4. Postmenopausal Metastatic Breast Cancer;American Journal of Cancer;2003

5. Chemotherapy for metastatic breast cancer–report of a European expert panel;The Lancet Oncology;2002-12